Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-01-03
2006-01-03
Fay, Zohreh (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S531000, C514S573000
Reexamination Certificate
active
06982283
ABSTRACT:
Provided is a method for treating drug-induced constipation comprising a step of administering an effective amount of a 15-keto-prostaglaindin compound to a subject suffering from drug-induced constipation or a subject having a strong possibility of suffering from it. According to the present invention, a strong antagonistic action against drug-induced constipation can be obtained without substantially losing the main effect of the drug.
REFERENCES:
patent: 5073569 (1991-12-01), Ueno et al.
patent: 5166174 (1992-11-01), Ueno et al.
patent: 5212324 (1993-05-01), Ueno
patent: 5221763 (1993-06-01), Ueno et al.
patent: 5317032 (1994-05-01), Ueno et al.
patent: 5739161 (1998-04-01), Ueno
patent: 6242485 (2001-06-01), Ueno
patent: 6414016 (2002-07-01), Ueno
patent: 2003/0022933 (2003-01-01), Ueno
The Merck Manual (“Constipation”, Fifteenth Edition, 1987, p. 776-777.
Harrison's Principles of Internal Medicine, 12th Edition, 1991, p. 378.
“The management of Constipation”, Prescribing Nurse Bulletin vol. 1, No. 6, 1999, pp. 21-25.
Twycross, R.G. et al., Constipation. In: Control: “Control of Alimentary Symptoms in Far Advanced Cancer”. Edinburgh: Churchill Livingstone, 1986: 166-207.
Culpepper-Morgan, J.A. et al., “Oral Naloxone Treatment of Narcotic Induced Constipation: Dose Response” NIDA Res. Monoger. 95: 399-400, 1989.
Culpepper-Morgan, J.A. et al., “Treatment of opioid-induced constipation with oral naloxone: A pilot study” Clinical Trials and Therapeutics. Clin Pharmacol Ther. 52: 90-95, 1992.
Sykes, N.P., “An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.” Palliative Medicice. 10: 135-144, 1996.
Christmas, A. J. The Mouse Anti-Morphine Constipation Test—A Simple Laboratory Test of the Gastrointestinal Side-Effect Potential of Orally Administered Prostaglandin Analogues. Prostaglandins 18, 279-284, 1979.
Broughton, B. J. “Uterine Stimulant Action of Some ω-Chain Modified (+)-11-Deoxyprostaglandins” Prostaglandins 22, 53-64, 1981.
Fay Zohreh
Kwon Brian-Yong
Sucampo AG
LandOfFree
Method for treating drug-induced constipation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating drug-induced constipation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating drug-induced constipation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581326